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Abstract
Background: It is well established that aging and vascular processes interact to
disrupt cerebral hemodynamics in older adults. However, the independent
effects of cerebral perfusion on neurocognitive function among older adults
remain poorly understood. We examined the associations among cerebral
perfusion, cognitive function, and brain structure in older adults with varying
degrees of vascular disease using perfusion magnetic resonance imaging (MRI)
arterial spin labeling (ASL). Materials and methods: 52 older adults underwent
neuroimaging and were administered the Mini Mental State Examination
(MMSE), the Repeatable Battery for the Assessment of Neuropsychological
Status (RBANS), and measures of attention/executive function. ASL and
T1-weighted MRI were used to quantify total brain perfusion, total brain
volume (TBV), and cortical thickness. Results: Regression analyses showed
reduced total brain perfusion was associated with poorer performance on the
MMSE, RBANS total index, immediate and delayed memory composites, and
Trail Making Test B. Reduced frontal lobe perfusion was associated with worse
executive and memory function. A similar pattern emerged between temporal
lobe perfusion and immediate memory. Regression analyses revealed that
decreased total brain perfusion was associated with smaller TBV and mean
cortical thickness. Regional effects of reduced total cerebral perfusion were
found on temporal and parietal lobe volumes and frontal and temporal cortical
thickness. Discussion: Reduced cerebral perfusion is independently associated
with poorer cognition, smaller TBV, and reduced cortical thickness in older
adults. Conclusion: Prospective studies are needed to clarify patterns of cogni-
tive decline and brain atrophy associated with cerebral hypoperfusion.
Introduction
It is well established that aging and vascular processes
interact to disrupt cerebral hemodynamics (Hoth 2010;
de la Torre 2012). Such effects on the cerebral circulation
system are unfortunate, as past work suggests reductions
in cerebral blood flow (CBF) is a known contributor to
cognitive impairment in older adults. For example, cere-
bral hypoperfusion is associated with increased risk for
neurological disorders (e.g., Alzheimer’s disease, vascular
dementia; Pakrasi and O’Brien 2005; Austin et al. 2011)
and has also been linked with more subtle deficits in
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nearly all domains of cognitive function in persons with
cardiovascular disease (CVD; Jefferson et al. 2007a,b;
Appleman et al. 2010; Moser et al. 2012).
The inverse association between CBF and cognitive func-
tion likely stems from the adverse effects of cerebral hypop-
erfusion on the brain (Jefferson et al. 2007a; Jerskey et al.
2009). Reduced CBF has been shown to predict decreased
brain volume in persons with diabetes (van Elderen et al.
2011). Measures of systemic perfusion (e.g., cardiac indi-
ces) also significantly correlate with abnormal brain aging
(e.g., smaller brain volume, white matter hyperintensities
[WMH]) in patients with cardiac disease (Jefferson et al.
2007b, 2010; Jefferson 2010). Extant evidence also shows
that reduced CBF is associated with structural and func-
tional brain abnormalities in a wide range of medical and
neurological populations (e.g., Alzheimer’s disease, stroke
patients; Austin et al. 2011; Aoi et al. 2012).
Despite these findings, the independent effects of cere-
bral perfusion on cognitive function and brain structure
remains poorly understood. Recent studies have used pos-
itron emission tomography (PET) and found global CBF
was inversely associated with cognitive test performance
among vascular disease patients; however, findings from
these studies are limited by small sample sizes and lack of
control for confounding comorbid medical conditions
that influence neurocognitive outcomes (Kitagawa et al.
2009; Brundel et al. 2012; Moser et al. 2012). Even fur-
ther, limited research has used arterial spin labeling (ASL)
to examine the relationship between CBF and neurocog-
nitive outcomes in aging older adults with CVD. This is
unfortunate, as rapidly growing attention has been paid
to the use of ASL imaging in detecting individuals at risk
for neurodegenerative disorders (e.g., Alzheimer’s
disease), including conversion from normal aging to
dementia (Chao et al. 2010; Alexopoulos et al. 2012;
Bangen et al. 2012; Wolk and Detre 2012). Past work also
shows ASL imaging is sensitive to brain perfusion
abnormalities in stroke survivors even before the onset of
structural brain injury – though this study was limited to
sample size of three participants (Brumm et al. 2010).
In light of these findings, ASL imaging may also serve
as a useful biomarker for poor neurocognitive outcomes
in aging older adults with CVD at risk for cognitive
impairment, though no study has examined this possibil-
ity. The purpose of the current study was to examine the
independent associations among cerebral perfusion using
ASL imaging, structural brain indices (e.g., volume and
cortical thickness), and cognitive test performance among
a larger sample of older adults with varying degrees of
vascular disease. In addition to the use of ASL imaging,
we also sought to extend past work by capturing the
independent effects of cerebral perfusion on the brain and
cognition through the adjustment of medical and demo-
graphic variables that negatively impact neurocognitive
outcomes in older adults.
Material and Methods
Participants
The sample consisted of 52 participants with complete neu-
ropsychological, medical, and demographic data (see
Table 1). This sample size was reduced from 95 due to miss-
ing data, however, those excluded were not significantly dif-
ferent in terms of age (t(92) = 0.99, P = 0.32), gender (v2
(1, N = 95) = 0.55, P = 0.46), education (t(83) = 1.70,
P = 0.09), global cognitive status (t(64.97) = 0.99,
P = 0.33), cardiac function (t(87) = 1.12, P = 0.27), or in
terms of comorbid medical conditions such as diabetes (v2
(1, N = 95) = 0.85, P = 0.36), though there was a trend for
hypertension (v2 (1, N = 95) = 3.83, P = 0.05). Participants
were recruited from either outpatient cardiology offices or
from advertisements in local papers. The inclusion criteria
were English-speaking and normal or corrected vision at the
time of testing. Potential participants were excluded for
significant neurological disease (e.g., history of stroke, mul-
tiple sclerosis), moderate or severe traumatic brain injury
Table 1. Demographic and medical characteristics (N = 52).
Demographic characteristics
Age, mean (SD) 65.73 (8.99)
Sex (% women) 57.7
Race (% Caucasian) 94.2
Education, mean (SD) 16.06 (2.56)
WTAR, mean (SD) 110.17 (7.52)
Medical characteristics
Cardiac index, mean (SD) 2.80 (0.58)
Heart rate, mean (SD) 64.62 (8.83)
Angina (%) 11.5
Atrial fibrillation (%) 9.6
Coronary artery disease (%) 19.2
Myocardial infarction (%) 11.5
Heart failure (%) 9.6
Hypertension (%) 42.3
Diabetes (%) 9.6
Elevated total cholesterol (%) 53.8
ACE inhibitor (%) 30.8
Antidysrhythmics (%) 7.7
Antihyperlipidemics (%) 55.8
Antihypertensive agents (%) 55.8
Neuroimaging findings
Total brain volume, mean (SD) 447,348.79 (47,746.92) mm3





376.45 (54.53) mL mg1 sec1
ACE, angiotensin-converting enzyme; WTAR, Wechsler Test of Adult
Reading.
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(with loss of consciousness), diagnosis of a current psychiat-
ric illness, history of substance abuse with subsequent hospi-
talization, or any contraindications for magnetic resonance
imaging (MRI; e.g., some metal implants). Participants were
administered a comprehensive neuropsychological battery.
Institutional Review Board approval was granted and writ-




All scans were performed using a 3 T Siemens Tim Trio
scanner (Siemens, Erlangen, Germany) located on the
Brown University campus. A 32 channel head receive array
was used with body resonator transmit coil, and participants
were placed head first in the supine position. Foam pads
were placed in the space around the head to limit motion,
and participants were provided with hearing protection in
the form of foam earplugs and headphones.
Following acquisition of a three-axis localizer scan, a
3D T1-MPRAGE scan was acquired with 1 mm isotropic
resolution. This scan was acquired using parameters
TR = 1900 msec, TE = 2.98 msec, TI = 900 msec, and
readout flip angle = 9 to provide a 3D T1 image dataset
for gray–white matter segmentation and morphometric
analyses. ASL scans were acquired using PICORE-Q2TIPS
(Wong et al. 1998; Luh et al. 1999), a Siemens product
sequence that is distributed with their MRI scanners. This
widely used pulsed ASL sequence has demonstrated reli-
ability and validity (Jahng et al. 2005; Liu and Brown
2007; Noguchi et al. 2007; Petersen et al. 2010).
In brief, differences between 71 pairs of tagged and
control ASL volumes were averaged to create individual
mean perfusion maps. Mean perfusion values were then
calculated for each individual by white matter, gray
matter using T1-MPRAGE segmentation boundaries (see
below). The Desikan–Killiany atlas was then used to cal-
culate mean perfusion values for each lobe. Specifically,
71 pairs (control, perfusion weighted) of motion cor-
rected images were averaged to provide the DM image for
perfusion map computation. The first image acquired in
the series served as the M0 image. An inversion slab
110 mm in thickness was placed with its proximal edge
12 mm from the inferior boundary of the imaged region.
Eighteen slices of 6 mm thickness were acquired over two
scans (nine slices in the first scan, eight slices in the sec-
ond). In-plane voxel size was 3 mm with slice thickness
of 6 mm. Timing parameters were TR = 2500 msec,
TI1 = 700 msec, TI2 = 1800 msec (inversion to start of
the 642 echo planar image readout sequence with
TE = 16 msec). Scan time for each ASL run was 4.5 min.
The M0 map for each slice was the first image acquired
in the dataset. This image was not acquired with any
inversion or saturation preparation and was taken with
the longitudinal magnetization at full equilibrium. DM
maps were formed by averaging the 71 pairs of motion-
corrected images. The M0 and DM maps were used to
produce perfusion maps for each slice using a Matlab
script (Math Works, Natick, MA) using the expression:
f ¼ DM
2aqM0TI1 expðTI2=T1aÞ
where DM is the difference signal, M0 is the equilibrium
magnetization (first frame of the series), a is the inversion
efficiency, TI1 is the interval from inversion to the double
saturation pulses, TI2 is the interval from inversion to
image readout, T1a is the arterial blood T1, and q is a
factor taking into account water exchange between the
vascular and interstitial compartments. TI2 was incre-
mented across the slices to account for the actual acquisi-
tion time for each slice relative to the inversion pulse. If
individual TI2 values are not used for each slice, progres-
sive underestimation of perfusion with advancing slice
position in the superior direction is seen with the most
distal image slice from the inversion slab showing the
greatest underestimation. The tissue parameters (Stanisz
et al. 2005; Zhu and Penn 2005; Wright et al. 2008) used
were T1a = 1664 msec, T1T =1300 msec (gray matter) or
1000 msec (white matter), Tex = 1000 msec, and
k = 0.9 mL/g. Inversion efficiency (a) was set to 0.95 based
on scanner manufacturer recommendation (a = 1 corre-

















where T1a is the arterial blood T1, T1T is the tissue T1, Tex is
the exchange time constant, f is perfusion, k is the blood–
brain water partition coefficient, and t is the interval
between arterial tagging and start of image acquisition.
Using the above tissue parameter values results in values of
q = 0.93 for gray matter and 0.85 for white matter. These
values of q were applied to the perfusion calculation on a
pixel basis based on gray–white matter tissue segmentation.
Cortical segmentation
T1 segmentation was accomplished by thresholding tissue
probability maps to determine the boundaries of white
and gray matter, which were used as region of interest
masks in ASL perfusion analyses. The Desikan–Killiany
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atlas was also used to calculate mean ASL perfusion for
each lobe. Thus, SPM5 tissue segmentation (Ashburner
and Friston 2008; Ashburner 2009) was applied to the
T1-MPRAGE data acquired during the same scanning
session as the perfusion acquisitions, generating gray
matter and white matter posterior probability maps for
each participant in native space. The posterior probability
maps were then thresholded using a minimum probability
of 0.70, minimizing partial volume effects for each tissue
type, yielding a binary gray matter mask and a binary
white matter mask. The T1-weighted anatomical acquisi-
tion was processed using FreeSurfer reconstruction (Dale
et al. 1999; Fischl et al. 1999), which generated separated
left and right cerebral hemisphere cortical ribbon masks
and cortical parcellation using the Desikan–Killiany atlas
for each participant. Left and right masks were combined
to form the cortical ribbon mask.
The whole brain geometry for each participant’s mean
perfusion data was established by concatenating the infe-
rior 9 axial slice and superior 9 axial slice relative CBF
maps generated by the scanner, along the slice (z) direc-
tion using Analysis of Functional Neuroimages (AFNI)
(Cox 1996). The AFNI MATLAB library, freely available
from http://afni.nimh.nih.gov/afni/matlab, was used to
convert each whole brain perfusion array into an AFNI-
compatible 3D format, having the same geometry as the
whole brain relCBF dataset. The FreeSurfer cortical ribbon,
anatomically based cortical parcellation (Desikan–Killiany
atlas) and binary masks, were then aligned with and re-
sampled to the same geometry as the perfusion data using
AFNI/SUMA (Surface Mapping with AFNI). A whole brain
perfusion map was then created using the following for-
mula: Whole brain perfusion = (binary gray matter
mask + binary white matter mask) 9 (perfusion data).
Alignment verification of the cortical ribbon mask,
cortical parcellation, whole brain mask, and whole brain
perfusion map in 3 mm 9 3 mm 9 6 mm space was
done for each participant using the AFNI viewer. Following
alignment and resampling, the mean and standard devia-
tion (SD) of all perfusion values between 1 and 100 was
calculated for each region of interest (as outlined in the
Desikan–Killiany atlas), the cortical ribbon, and the whole
brain. Left and right hemisphere frontal, temporal, parietal,
and occipital lobe perfusion composites were also computed
that consisted of the sum of the perfusion values of the
respective regions of interest for each lobe.
Morphometric analyses
For morphometric analyses, T1 volumes were segmented
into gray, white, cerebrospinal fluid, and nonbrain tissues
using the FreeSurfer software package. Gray and white
matter volume and thickness were then calculated and
Desikan’s atlas was applied to calculate thickness and vol-
ume by atlas region. These procedures are based on estab-
lished techniques and procedures for the surface and
subcortical reconstruction and have been described previ-
ously (Fischl and Dale 2000; Fischl et al. 2004; Han et al.
2006). The fully automated FreeSurfer v5.0 recon-all pro-
cessing stream was completed for 52 participants. After
preprocessing, results underwent quality control to con-
firm absence of any errors or defects in the segmentation.
Summary composites of volume and the mean of cortical
thickness of each brain region including frontal, temporal,
parietal, and occipital were also calculated using the orga-
nization schema as described in Desikan et al. (2006).
Physiological examination
Participants’ weights and heights were measures to calcu-
late body mass index (BMI) using the standard formula:
(mass in kg)/(height in meters)2. A transthoracic echocar-
diogram was conducted with two-dimensional apical
views from each participant according to standards of the
American Society of Echocardiography (Lang et al. 2005).
Cardiac index was calculated by dividing cardiac output
by BMI, which yielded a measure of cardiac output that
controlled for body size.
Neurocognitive assessment
All participants completed a standardized neuropsychologi-
cal assessment by trained research assistants under the
supervision of a licensed clinical neuropsychologist. For the
purposes of the current work, the primary cognitive mea-
sures included the Repeatable Battery for the Assessment of
Neuropsychological Status (RBANS; Randolph et al. 1998)
and the Mini Mental State Examination (MMSE; Folstein
et al. 1975). The RBANS is a brief battery that consists of
10 subtests that divide into five index scores: (1) Immediate
memory – leaning verbal information presented in list and
story formats; (2) Language – confrontation naming and
semantic fluency; (3) Visuospatial/Construction – produc-
tion of a complex figure and a modified judgment of line
orientation; (4) Attention – digit span and coding;
(5) Delayed Memory – recall of verbal learning tasks and
complex figure after a brief delay. Performance on this
measure is reported in Standard Scores with a mean of 100
and standard deviation of 15. Finally, the MMSE was used
to assess global cognitive function. It is a brief screening
measure that assesses aspects of attention, orientation,
memory, language, and calculation (Folstein et al. 1975).
The range of scores extends from 0 to 30. To more fully
capture attention/executive function in the sample partici-
pants were also administered the Trail Making Test A and
B (TMT A and B; Reitan 1958). The TMT A requires par-
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ticipants to connect a series of letters in sequential order as
quickly as possible. TMT B asks participants to alternately
connect a series of letters and numbers as quickly as
possible.
Estimated premorbid intelligence
To assess premorbid intelligence, the Wechsler Test of
Adult Reading (WTAR) was administered to all partici-
pants. The WTAR is recognized as a valid method to esti-
mate premorbid intelligence (Green et al. 2007). During
this test, individuals are asked to read aloud a list of 50
irregularly pronounced words. Estimated IQ based on the
WTAR was used in the current analyses to control for the
effects of premorbid intelligence on neurocognitive func-
tion. Premorbid IQ taps into innate intelligence and is a
sensitive marker of cognitive reserve (Alexander et al. 1997).
Demographic and medical characteristics
The patient’s medical history and currently prescribed
medications were self-reported during two interviews and
confirmed by medical records when possible. Medications
were categorized by class and those identified as cardio-
vascular medications were reviewed and confirmed by a
clinical cardiologist.
Statistical analyses
All RBANS composite scores were converted to standard
scores (i.e., a distribution with a mean of 100 and a stan-
dard deviation of 15) adjusted for age using normative
values. Normative data for the RBANS composite was
used in order to facilitate clinical interpretation of cogni-
tive status in the current sample. TMT A and B scores
were also converted to standard scores for similar reason-
ing. A composite of gray matter volume and cortical
thickness of each brain region including frontal, temporal,
parietal, and occipital lobes were calculated using the
organization schema as described in Desikan et al. (2006).
Total brain volume (TBV) and thickness consisted of the
sum and average of the frontal, temporal, parietal, and
occipital lobe gray matter, respectively. All analyses exam-
ining brain volume and thickness were adjusted for intra-
cranial volume. Lastly, a total brain perfusion composite
was also computed that consisted of the mean perfusion
to the left and right hemispheres of the frontal, temporal,
parietal, and occipital lobe gray matter. For analyses
examining regional perfusion, the average of the left and
right hemispheres for each lobe was computed. One par-
ticipant exhibited missing data for occipital lobe perfusion
and total brain perfusion for this participant consisted of
the average of the remaining lobes. There was also one
case with missing data on TMT B and this case was
excluded from analyses examining this cognitive test as
the dependent variable.
Separate multivariable hierarchical regression analyses
were performed for the MMSE, each RBANS composite,
TMT A, and TMT B. For each model, demographic and
medical characteristics were entered in block 1 that
included: Age, sex (1 = male; 1 = female), premorbid
intelligence (as estimated by the WTAR), cardiac index,
heart rate, diagnostic history of hypertension, diabetes,
and atrial fibrillation (1 = positive history; 0 = negative
history). Total brain cerebral perfusion was then entered
into block two of each model to determine its incremen-
tal predictive validity on cognitive function. To clarify
significant findings, follow-up regression analyses control-
ling for the above medical and demographic factors were
then conducted that examined perfusion to brain lobes
responsible for the mental abilities that demonstrated a
significant association with total brain perfusion.
Regression analyses then examined the predictive valid-
ity of cerebral perfusion on TBV and total brain cortical
thickness after accounting for the above-mentioned medi-
cal and demographic variables in addition to intracranial
volume. A final series of regression analyses controlling
for medical and demographic characteristics and intracra-
nial volume were also performed to determine whether
TBV and total brain cortical thickness predicted the
MMSE, RBANS total index composite scores, and TMT A
and B. Of note, comorbid vascular risk factors (e.g., dia-
betes, hypertension, atrial fibrillation, cardiac dysfunction)
introduce multiple physiological processes that adversely
impact cognition and brain structure in older adults.
In-turn, this study included the aforementioned medical
and demographic variables as covariates in order to
identify the independent effects of cerebral perfusion on
neurocognitive outcomes in older adults.
Results
Sample medical characteristics
The sample demonstrated an average cardiac index of
2.80 (SD = 0.58). Overall, 19.2% of the sample exhibited
a positive diagnostic history of coronary artery disease,
11.5% angina, 11.5% myocardial infarction, and 9.6%
had a heart failure diagnosis. CVD risk factors were also
prevalent with nearly 42.3% of the sample having hyper-
tension and 53.8% elevated total cholesterol. Prescribed
CVD medication was also prevalent in this sample with
more than half of participants prescribed antihyperlipi-
demics and antihypertensive agents. See Table 1 for
complete medical and demographic characteristics of the
sample.
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Bivariate correlations examined the associations
between cortical lobar cerebral perfusion and key CVD
variables, including cardiac index, heart rate, and hyper-
tension. Analyses revealed that hypertension was associ-
ated with reduced temporal lobe (r(50) = 0.36,
P = 0.01) and occipital lobe perfusion (r(49) = 0.36,
P = 0.01). Increased heart rate was also associated with
decreased frontal lobe (r(50) = 0.27, P = 0.06) and occipi-
tal lobe perfusion (r(49) = 0.29, P = 0.04). Lastly, reduced
cardiac index demonstrated a trend with lower cerebral
perfusion of the temporal lobe (r(50) = 0.23, P = 0.097). No
other significant findings between cerebral perfusion and the
above CVD markers emerged (P > 0.05 for all).
Cognitive status
The average MMSE score of the current sample was 29.06
(SD = 1.46). Similar to MMSE performance, the sample
exhibited an average RBANS total index score of 106.40
(SD = 12.80). However, examination of the RBANS com-
posites showed that many participants exhibited impair-
ments across multiple domains of cognitive function with
the most prevalent deficits found on the RBANS visuo-
spatial/construction composite (15.4%). Impairments on
TMT A and B were less common (see Table 2).
Cerebral perfusion and cognitive function
Block 1 of the model examined the association between
medical and demographic variables with the MMSE, each
RBANS composites, and TMT A and B. Taken together,
medical and demographic variables demonstrated a
significant association with the RBANS immediate memory
composite (F(8, 43) = 2.73, P = 0.02) and a trend for the
MMSE (F(8,43) = 2.05, P = 0.06). Block 2 then examined
the association between total brain perfusion with the
MMSE, each RBANS composite, and TMT B after
accounting for medical and demographic variables
entered in block 1. Total brain perfusion exhibited signifi-
cant associations with the following cognitive variables:
MMSE, RBANS immediate memory composite, RBANS
delayed memory composite, RBANS total index compos-
ite, and TMT B. In each case, reduced cerebral perfusion
was associated with poorer cognitive function. No such
pattern emerged for any of the other RBANS composites
or TMT A (P > 0.05 for all). Refer to Table 3.
Regional cerebral perfusion and cognitive
function
In light of the specific associations between total brain
perfusion with memory performance and TMT B, follow-
up hierarchical regression analyses were conducted to
examine the association between cerebral perfusion to
cortical lobes important for learning, memory, and execu-
tive function (e.g., frontal and temporal lobe) with the
RBANS immediate and delayed memory composite and
TMT B. After controlling for medical and demographic
variables, reduced cerebral perfusion of both the frontal
(b = 0.51, P < 0.01; R2 = 0.53) and temporal lobe
(b = 0.29, P = 0.05; R2 = 0.39) was associated with
poorer performance on the RBANS immediate memory
composite. Decrease perfusion to the frontal lobe also
demonstrated an association with worse performance on
the RBANS delayed memory composite (b = 0.32,
P = 0.06; R2 = 0.14), though there was no association
between the temporal lobe and the RBANS delayed mem-
ory composite (b = 0.24, P = 0.19; R2 = 0.10). Similarly,
reduced frontal lobe perfusion exhibited significant pre-
dictive validity for poorer performance on the TMT B
(b = 0.55, P = 0.02; R2 = 0.37).
Cerebral perfusion and magnetic resonance
imaging findings
After adjustment of medical characteristics, demographic
variables, and intracranial volume entered in block 1,
the second block of the model with total brain perfu-
sion exhibited significant predictive validity for TBV
and total brain cortical thickness. Decreased CBF was
associated with smaller TBV and reduced cortical thick-
ness. See Table 4 for a full summary of cerebral perfu-
sion and MRI regression analyses. TBV and total brain
cortical thickness were not associated with the MMSE,
RBANS total index composite, or TMT A or B perfor-
mances (P > 0.05 for all).
Table 2. Descriptive statistics of cognitive test performance (N = 52).






105.60 (13.48) 7.7 73–129
RBANS visuospatial/
construction
104.83 (15.56) 15.4 60–136
RBANS language 103.88 (11.75) 1.9 80–133
RBANS attention 105.12 (13.32) 7.7 68–138
RBANS delayed
memory
103.40 (12.489) 7.7 60–126
RBANS total index 106.40 (12.80) 5.8 73–136
Attention/executive function1
Trail Making Test A 11.98 (2.55) 3.8 3–16
Trail Making Test B 11.59 (2.74) 5.9 3–15
1Scores for Trail Making Test A and B are scaled scores; one partici-
pant exhibited missing data on Trail Making Test B.
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Cerebral perfusion and cortical lobar
volume and thickness
Follow-up regression analyses controlling for medical char-
acteristics, demographic variables, and intracranial volume
were performed to examine the association between cere-
bral perfusion and cortical lobar volumes and thickness.
Significant associations were found between cerebral hyp-
operfusion with decreased volume for the temporal lobe (F
(1, 41) = 12.92, P = 0.01; b = 0.25) and a strong trend for
the parietal lobe (F(1, 41) = 3.56, P = 0.07; b = 0.19). No
such pattern emerged for the frontal or occipital lobe
(P > 0.10 for all). Decreased CBF was also associated with
reduced frontal (F(1, 41) = 5.23, P = 0.03; b = 0.36) and
temporal (F(1, 41) = 9.91, P < 0.01; b = 0.44) cortical
thickness. There was no association between brain perfu-
sion with parietal or occipital cortical thickness (P > 0.10
for all).
Discussion
Consistent with past work, cognitive dysfunction was
evident in this representative sample of older adults
with CVD. The current study extends past findings by
showing that CBF as assessed through ASL is associated
with cognitive function and also correlated with mea-
sures of cerebral morphometry in older adults, even
after controlling for key medical and demographic
Table 3. Hierarchical multiple linear regression models examining the predictive validity of total brain perfusion on cognitive function (N = 52).
Cognitive variables
Immed.
mem. Visuo Lang Atten.
Delay
memory Total MMSE TMTA TMTB
b (SE) b (SE) b (SE) b (SE) b (SE) b (SE b) b (SE) b (SE) b (SE)
Block 1
Age 0.05 (0.21) 0.06 (0.29) 0.01 (0.20) 0.05 (0.22) 0.00 (0.23) 0.06 (0.22) 0.29 (0.02) 0.03 (0.05) 0.21 (0.05)
Sex 0.14 (1.89) 0.02 (2.61) 0.22 (1.80) 0.17 (1.99) 0.03 (2.08) 0.16 (0.41) 0.23 (0.21) 0.16 (0.41) 0.05 (0.43)
WTAR 0.20 (0.24) 0.16 (0.33) 0.23 (0.23) 0.39 (0.25)* 0.15 (0.26) 0.32 (0.24)* 0.27 (0.03) 0.13 (0.05) 0.39 (0.05)
CI 0.26 (3.39) 0.02 (4.68) 0.02 (3.23) 0.15 (3.57) 0.07 (3.73) 0.07 (3.48) 0.13 (0.38) 0.08 (0.74) 0.15 (0.76)
HR 0.18 (1.28) 0.07 (0.29) 0.03 (0.20) 0.07 (0.22) 0.08 (0.23) 0.06 (0.22) 0.02 (0.02) 0.19 (0.05) 0.11 (0.05)
HTN 0.20 (3.65) 0.06 (5.05) 0.26 (3.49) 0.26 (3.85) 0.09 (4.02) 0.06 (3.75) 0.16 (0.41) 0.21 (0.79) 0.14 (0.83)
DM 0.16 (6.14) 0.04 (8.48) 0.10 (5.86) 0.09 (6.46) 0.11 (6.75) 0.13 (6.30) 0.02 (0.70) 0.00 (1.33) 0.07 (1.39)
AFIB 0.01 (5.91) 0.00 (8.16) 0.11 (5.64) 0.02 (6.22) 0.10 (6.50) 0.02 (6.07) 0.04 (0.67) 0.11 (1.28) 0.10 (1.32)
R2 0.34 0.05 0.21 0.25 0.07 0.22 0.28 0.12 0.21
F 2.73* 0.29 1.39 1.77 0.38 1.55 2.05 0.76 1.35
Block 2
Perfusion 0.42 (0.03)** 0.05 (0.05) 0.23 (0.04) 0.25 (0.04) 0.34 (0.04)* 0.35 (0.04)* 0.31 (0.00)* 0.22 (0.01) 0.41 (0.01)*
R2 0.46 0.05 0.24 0.29 0.15 0.31 0.34 0.16 0.32
F for DR2 9.22** 0.08 1.90 2.44 3.92* 5.08* 4.11* 1.66 6.70*
Immed. memory, immediate memory; Visuo, visuospatial/construction; Lang, language; Atten, attention; Total, total index; TMT, Trail Making Test;
WTAR, Wechsler test of adult reading; CI, cardiac index; HR, heart rate; HTN, hypertension; DM, diabetes mellitus; AFIB, atrial fibrillation. Sample
size for TMT B = 51.
*P ≤ 0.05.
**P ≤ 0.01.
Table 4. Hierarchical multiple linear regression models examining the
predictive validity of total brain perfusion on total brain volume and





b (SE b) b (SE b)
Block 1
Age 0.39 (404.65)** 0.48 (0.00)**
Sex 0.11 (4288.64) 0.00 (0.02)
WTAR 0.03 (448.37) 0.08 (0.00)
CI 0.00 (6434.95) 0.05 (0.03)
HR 0.10 (399.93) 0.05 (0.00)
HTN 0.03 (6929.64) 0.13 (0.03)
DM 0.13 (11,824.38) 0.08 (0.05)
AFIB 0.01 (11,185.86) 0.18 (0.05)




Perfusion 0.16 (67.69)* 0.35 (0.00)*
R2 0.83 0.35
F for DR2 4.38* 5.25*
WTAR, Wechsler test of adult reading; CI, cardiac index; HR, heart
rate; HTN, hypertension; DM, diabetes mellitus; AFIB, atrial fibrillation;
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factors. Several aspects of these findings warrant brief
discussion.
The current study suggests that reduced cerebral blood
is associated with poorer cognitive function, particularly
on tests of memory and attention/executive function.
These findings are consistent with past work that shows
the adverse impact of reduced CBF on cognitive function
in vascular disease and neurological populations (e.g.,
Alzheimer’s disease; Moren et al. 2005; Moser et al.
2012). The specific adverse effects of hypoperfusion on
memory performance in the current sample is interesting
in light of recent work also employing ASL imaging that
suggests altered cerebral hemodynamics is a significant
contributor to the pathogenesis of Alzheimer’s disease
(Austin et al. 2011; Alexopoulos et al. 2012; Bangen et al.
2012). This pattern is noteworthy given the elevated risk
of Alzheimer’s disease in persons with CVD (Qiu et al.
2006). Indeed, a specific correlation between temporal
lobe perfusion and memory emerged in the current
sample. The temporal lobe consists of regions of the brain
that help mediate memory abilities (e.g., hippocampus)
and are sensitive to the effects of aging and also particu-
larly susceptible to hypoxic episodes stemming from fluc-
tuations in CBF levels (Ruittenberg et al. 2005).
Prospective studies are needed to fully clarify the exact
role of cerebral perfusion in memory decline, including
its role in the development of Alzheimer’s disease.
The current study also found a specific association
between cerebral perfusion of the frontal lobe and per-
formance on a test of executive function. This is note-
worthy, as executive dysfunction is common in older
adults with vascular disease (Roman et al. 2004) and
may be a result of reduced oxygenation to the highly
plastic frontal lobes subsequent to disrupted cerebral he-
modynamics. It is also possible that memory deficits in
this sample may involve frontal-subcortical dysfunction
(e.g., encoding, organizing) given the current association
between frontal lobe perfusion and memory (Bonelli and
Cummings 2008). Similarly, successful aging is com-
monly characterized by preserved prefrontal activation,
which also corresponds to better memory on cognitive
testing (Rosen et al. 2002). Nonetheless, hypoperfusion is
believed to be sensitive to the early stages of cognitive
impairment (Austin et al. 2011) and prospective studies
are needed to elucidate patterns of cognitive decline that
corresponds with cerebral hypoperfusion in aging and
CVD populations.
The current findings also demonstrated an association
among cerebral perfusion and smaller TBV and reduced
cortical thickness. Although the cross-sectional design of
the current study precludes interpretation of directional-
ity, such findings raise the possibility that cerebral hypop-
erfusion is a significant contributing factor to adverse
brain changes. However, future work is needed to clarify
this possibility, as it is also possible that the development
of vascular lesions (e.g., WMH) disrupts cerebral perfu-
sion (Bastos-Leite et al. 2008). Brief disruptions in CBF
are maintained in healthy individuals through autoregula-
tory mechanisms, though such mechanisms can become
compromised in the presence of older age and vascular
disease (Choi et al. 2006; Hoth 2010). Extant evidence
suggests that such disruptions in cerebral hemodynamics
may lead to adverse brain changes. For instance, cerebral
hypoperfusion has been linked with accelerated brain
atrophy in neurodegenerative disorders (e.g., Alzheimer’s
disease, Huntington’s disease; Luckhaus et al. 2010; Li
et al. 2010; Chen et al. 2012). Moreover, the association
between reduced cerebral perfusion and cortical thickness
in this study is noteworthy, as cortical thinning is a
significant predictor of conversion from mild cognitive
impairment to Alzheimer’s disease (Querbes et al. 2009;
Austin et al. 2011). The positive correlation between cere-
bral hypoperfusion and the temporal lobe structure in the
current study also provides possible support for altered
cerebral hemodynamics as a risk factor for dementia-
related processes, though this awaits empirical test using
longitudinal study designs. Indeed, prospective studies are
needed to elucidate the potential negative impact of cere-
bral hypoperfusion on brain structure and associated risk
with neurological changes (e.g., Alzheimer’s disease).
The novelty of ASL imaging used in the current study
deserves brief discussion. ASL MRI imaging has become
increasingly popular method to assess cerebral perfusion
because of its noninvasive nature (Austin et al. 2011).
More importantly, ASL directly assesses CBF through the
use of a magnetically labeled arterial blood water endoge-
nous tracer (Aslop et al. 2010; Austin et al. 2011). The
technological and also economic benefits of ASL may be
advantageous over other imaging modalities that assess
cerebral perfusion (e.g., PET, single-photon emission
computed tomography (SPECT)), though future studies
should examine ASL versus PET versus SPECT measured
blood flow in older adult CVD patients as they relate to
cognition and adverse brain changes.
The generalizability of the current findings is limited
in several ways. First, the current study consisted of
cross-sectional analyses and prospective studies are
needed to determine whether cerebral hypoperfusion
leads to cognitive decline and accelerated brain atrophy
and cortical thinning in older adults. However, the sug-
gested direction of these effects over time is supported
by past work (Kitagawa et al. 2009). In addition, the
current study found no association between brain vol-
ume or cortical thickness and cognitive function, and
additional work is needed to clarify this pattern. Indeed,
range restriction may have limited the current findings,
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as this sample exhibited relatively intact cognition and
future studies with larger more diverse samples would
increase the external validity. Consistent with this
notion, the current study attempted to control for key
medical covariates that influence neurocognitive out-
comes, though larger sample sizes are needed to confirm
our findings through increased statistical power and sub-
sequent adjustment of other important possible con-
founds (e.g., white matter lesions, medication side
effects). Similarly, prospective studies should examine
the role of CBF in the development of white matter
lesions, as recent work in CVD patients shows that
WMH may be a key contributor to cognitive impair-
ment (Alosco et al. 2013). Likewise, it is also possible
that WMH leads to reduced CBF to exacerbate brain
injury and cognitive impairment, as suggested by past
work using ASL imaging in elderly subjects with diffuse
confluent WMH (Bastos-Leite et al. 2008). Consistent
with this notion, future work should also quantify and
examine the contribution of silent infarcts and brain mi-
crobleeds to neurocognitive outcomes in aging CVD
populations, particularly as they affect cerebral perfusion
and subsequent neurocognitive outcomes. Lastly, cerebral
perfusion may also be a more sensitive marker of early
cognitive impairment relative to subclinical cerebral atro-
phy in the context of the normal aging process.
In brief summary, the current study found that reduced
cerebral perfusion as measured by ASL is associated with
poorer neurocognitive function in older adults, including
reduced cognitive function, smaller TBV, and reduced
cortical thickness. Although the current study supports
the widely proposed etiology of cerebral perfusion in
older adults, prospective studies are needed to confirm
our findings and better clarify the patterns of cognitive
decline and brain atrophy associated with cerebral hypop-
erfusion.
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